Steven Lo Biography and Net Worth

Steven Lo is our Chief Executive Officer and member of the board of directors.  Steve was previously the chief commercial officer at Puma Biotechnology where he built the commercial operations infrastructure and team to launch the company’s first product, NERLYNX®, in the United States while leading the execution of global licensing agreements for rest of world. Previously, he was senior vice president and chief commercial officer at Corcept Therapeutics. At Corcept, Mr. Lo formed the commercial organization to launch the company’s first product, Korlym®, an endocrine specialty medication for a rare orphan disease (Cushing’s syndrome) and also was responsible for the corporate strategy and development of the company’s oncology franchise. Earlier in his career, he spent 13 years at Genentech in increasingly responsible roles in market access, sales and marketing, ultimately serving as franchise head, Endocrinology. He started his career in the pharmaceutical industry at AstraZeneca after holding roles in finance and operations at Kaiser Permanente. Mr. Lo holds a master’s in health administration from the University of Southern California and a B.S. in microbiology from the University of California, Davis.